SCOPUS 정보 검색 플랫폼

Journal of Nuclear Medicine

Volumn 41, Issue 12, 2000, Pages 2011-2014

How far have we come with solid (nonhematologic) tumor radioimmunotherapy?

(1) Breitz, H B a

a VIRGINIA MASON MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; RHENIUM 186;

CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; HEAD AND NECK CARCINOMA; HUMAN; ISOTOPE LABELING; NOTE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SOLID TUMOR;

ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RECOMBINANT FUSION PROTEINS; RHENIUM;

EID: 0034518567 PISSN: 01615505 EISSN: None Source Type: Journal
DOI: None Document Type: Note

Times cited : (5)

References (25)

1
- 0021720579
- Radionuclide selection and model absorbed dose calculations for radiolabeled tumor-associated antibodies
- (1984) Med Phys , vol.11 , pp. 638-675
- Wessels, B.¹ Rogus, R.B.²

2
- 0034519646
- 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck
- (2000) J Nucl Med , vol.41 , pp. 1999-2010
- Colnot, D.R.¹ Quak, J.J.² Roos, J.C.³

3
- 4244043852
- Rhenium 186/-188 labeled antibodies for radioimmunotherapy
- Technetium and Rhenium in Chemistry and Nuclear Medicine. Verona, Italy: Cortina International
- (1990) , pp. 616-621
- Fritzberg, A.R.¹ Vanderheyden, J.-L.² Morgan, A.C.³ Schroff, R.W.⁴ Abrams, P.G.⁵

4
- 0026634188
- 186rhenium labeled monoclonal antibodies for radioimmunotherapy: Results of phase 1 trials
- (1992) J Nucl Med , vol.33 , pp. 1099-1109
- Breitz, H.B.¹ Weiden, P.L.² Vanderheyden, J.-L.³

5
- 0027273518
- 99mTc-labeled antibodies and results of phase I trials
- (1993) J Nucl Med , vol.34 , pp. 908-917
- Breitz, H.B.¹ Fisher, D.R.² Weiden, P.L.³

6
- 0027136012
- 186Re) labeled chimeric antibody NR-LU-13: Pharmacokinetics, biodistribution and immunogenicity relative to murine analogue NR-LU-10
- (1993) J Nucl Med , vol.34 , pp. 2111-2119
- Weiden, P.L.¹ Breitz, H.B.² Seiler, C.A.³

7
- 0032741274
- Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study
- (1999) Clin Cancer Res , vol.5 , Issue.SUPPL.
- Behr, T.M.¹ Salib, A.L.² Liersch³

8
- 0033561012
- 2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma
- (1999) Cancer , vol.85 , pp. 1828-1842
- Juweid, M.E.¹ Hajjar, G.² Swayne, L.C.³

9
- 0032694512
- 131I-labeled chimeric monoclonal antibody G250
- (1999) Clin Cancer Res , vol.5 , Issue.SUPPL.
- Steffens, M.G.¹ Boerman, O.C.² De Mulder, P.H.³

10
- 0032910019
- 90Y-based radioimmunotherapy
- (1999) Med Phys , vol.5 , pp. 799-809
- Clarke, K.G.¹ Odom-Maryon, T.L.² Williams, L.E.³

11
- 0033625513
- 111In-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma
- (2000) J Nucl Med , vol.41 , pp. 952-958
- DeNardo, G.L.¹ O'Donnell, R.T.² Shen, S.³

12
- 15444344197
- Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody I patients with advanced breast cancer
- (1998) Clin Cancer Res , vol.4 , pp. 1679-1688
- Kramer, E.L.¹ Liebes, L.L.² Wasserheit, C.³

13
- 0001938686
- Bone marrow dosimetry model adjustments based on age, gender and prior therapy
- (2000) J Nucl Med , vol.41 , Issue.SUPPL.
- Wessels, B.¹ Breitz, H.² Meredith, R.³

14
- 0031694161
- Marrow toxicity and radiation absorbed dose estimates from rhenium-186-labeled monoclonal antibody
- (1998) J Nucl Med , vol.39 , pp. 1746-1751
- Breitz, H.B.¹ Fisher, D.R.² Wessels, B.³

15
- 0034050410
- 99mTc-labeled anti-NCA-95 MAbs
- (2000) J Nucl Med , vol.41 , pp. 531-537
- Kotzerke, J.¹ Glatting, G.² Seitz, U.³

16
- 4244181077
- 99mTc(V)DMSA scans for radionuclide therapy planning
- (2000) J Nucl Med , vol.41 , Issue.SUPPL.
- Blower, P.J.¹ Kettle, A.G.² O'Doherty, M.J.³ Coakely, A.J.⁴ Knapp, F.F.⁵

17
- 4243452778
- 166Ho-DOTMP bone marrow ablation therapy
- (2000) J Nucl Med , vol.41 , Issue.SUPPL.
- McCullough, S.P.¹ Wendt, R.E.² Zareneyrizi, F.³ Simon, J.⁴ Podoloff, D.A.⁵

18
- 0033976335
- Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy
- (2000) Cancer Biother Radiopharm , vol.15 , pp. 71-79
- DeNardo, S.J.¹ Burke, P.A.² Leigh, B.R.³

19
- 0032862227
- Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct
- (1999) Clin Cancer Res , vol.9 , pp. 2613-2619
- Pavlinkova, G.¹ Booth, B.J.² Batra, S.K.³ Colcher, D.⁴

20
- 0033991523
- Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas
- (2000) Int J Cancer , vol.85 , pp. 104-112
- Johnson, T.A.¹ Press, O.W.²

21
- 0032737422
- Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenografts
- (1999) J Cancer Res Clin Oncol , vol.125 , pp. 630-636
- Kinuya, S.¹ Yokoyama, K.² Tega, H.³

22
- 0032697130
- Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer
- (1999) Clin Cancer Res , vol.10 , Issue.SUPPL.
- Stein, R.¹ Juweid, M.² Zhang, C.H.³ Goldenberg, D.M.⁴

23
- 0033199028
- Pretargeting of renal cell carcinoma: Improved tumor targeting with a bivalent chelate
- (1999) Cancer Res , vol.59 , pp. 4400-4405
- Boerman, O.C.¹ Kranenborg, M.H.² Oosterwijk, E.³

24
- 0033039587
- Pretargeting with the affinity enhancement system for radioimmunotherapy
- (1999) Cancer Biother Radiopharm , vol.3 , pp. 153-166
- Barbet, J.¹ Kraeber-Bodere, F.² Vuillez, J.-P.³ Gautherot, E.⁴ Rouvier, E.⁵ Chatal, J.-F.⁶

25
- 0033972577
- 90Y-DOTA-biotin
- (2000) J Nucl Med , vol.41 , pp. 131-140
- Breitz, H.B.¹ Weiden, P.L.² Beaumier, P.L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.